NASDAQ:LSAQ

LifeSci Acquisition II Stock Forecast, Price & News

$10.75

-0.44 (-3.93 %)

(As of 01/27/2021 12:00 AM ET)

Add

Compare

Today's Range

$10.51

Now: $10.75▼

$10.97

50-Day Range

$10.32

MA: $10.82▼

$11.52

52-Week Range

$9.96

Now: $10.75▼

$12.68

Volume21,628 shs

Average Volume23,705 shs

Market Capitalization$100.78 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

LifeSci Acquisition II Corp. intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the healthcare industry. The company was founded in 2019 and is based in New York, New York.

Overall MarketRank^™

0.00 out of 5 stars

Unclassified Sector

168th out of 247 stocks

Holding & Other Investment Offices Industry

147th out of 204 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for LifeSci Acquisition II.

0.0 Community Rank

Outperform Votes
LifeSci Acquisition II has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
LifeSci Acquisition II has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about LifeSci Acquisition II and other stocks. Vote “Outperform” if you believe LSAQ will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LSAQ will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
LifeSci Acquisition II does not currently pay a dividend.
Dividend Growth
LifeSci Acquisition II does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, LifeSci Acquisition II insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Holding & other investment offices

Sub-IndustryN/A

SectorUnclassified

Current SymbolNASDAQ:LSAQ

Previous Symbol

CUSIPN/A

CIKN/A

WebN/A

Phone646 889 1200

EmployeesN/A

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares9,375,000

Market Cap$100.78 million

Next Earnings DateN/A

OptionableNot Optionable

$10.75

-0.44 (-3.93 %)

(As of 01/27/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive LSAQ News and Ratings via Email

Sign-up to receive the latest news and ratings for LSAQ and its competitors with MarketBeat's FREE daily newsletter.

LifeSci Acquisition II (NASDAQ:LSAQ) Frequently Asked Questions

What stocks does MarketBeat like better than LifeSci Acquisition II?

Wall Street analysts have given LifeSci Acquisition II a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but LifeSci Acquisition II wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of LifeSci Acquisition II's key competitors?

Some companies that are related to LifeSci Acquisition II include Vector Acquisition (VACQ), CHP Merger (CHPM), New Providence Acquisition (NPA), GX Acquisition (GXGX), Dragoneer Growth Opportunities Corp. II (DGNS), Replay Acquisition (RPLA), Alussa Energy Acquisition (ALUS), Capstar Special Purpose Acquisition (CPSR), Yucaipa Acquisition (YAC), Property Solutions Acquisition (PSAC), Kismet Acquisition One (KSMT), Empower (EMPW), Oaktree Acquisition Corp. II (OACB), FG New America Acquisition (FGNA) and FTAC Olympus Acquisition (FTOC).
View all of LSAQ's competitors.

Who are LifeSci Acquisition II's key executives?

LifeSci Acquisition II's management team includes the following people:

Dr. Andrew Ian McDonald Ph.D., Chairman & CEO (Age 48)
Mr. David Dobkin, CFO, Head of Strategy & Director (Age 42)
Mr. Michael Yehuda Rice, COO & Director (Age 56)

When did LifeSci Acquisition II IPO?

(LSAQ) raised $75 million in an initial public offering on Friday, November 20th 2020. The company issued 7,500,000 shares at $10.00 per share. LifeSci Capital and Ladenburg Thalmann acted as the underwriters for the IPO.

What is LifeSci Acquisition II's stock symbol?

LifeSci Acquisition II trades on the NASDAQ under the ticker symbol "LSAQ."

When did LifeSci Acquisition II's quiet period expire?

LifeSci Acquisition II's quiet period expired on Wednesday, December 30th. LifeSci Acquisition II had issued 7,500,000 shares in its IPO on November 20th. The total size of the offering was $75,000,000 based on an initial share price of $10.00. During LifeSci Acquisition II's quiet period, insiders and underwriters involved in the IPO were restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of LifeSci Acquisition II?

Shares of LSAQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is LifeSci Acquisition II's stock price today?

One share of LSAQ stock can currently be purchased for approximately $10.75.

How big of a company is LifeSci Acquisition II?

LifeSci Acquisition II has a market capitalization of $100.78 million.

How can I contact LifeSci Acquisition II?

The company can be reached via phone at 646 889 1200.

This page was last updated on 1/28/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here